<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">miR--p </span>
   <span class="font26">cells </span>
   <span class="font17">HCT- </span>
   <span class="font17">(). </span>
   <span class="font17">PDMAEMA-NP </span>
   <span class="font16">cancer </span>
   <span class="font16">nanocomplexes </span>
   <span class="font16">CRC </span>
   <span class="font15">tumor </span>
   <span class="font15">cell </span>
   <span class="font15">-Fu </span>
   <span class="font15">vs. </span>
   <span class="font14">effect </span>
   <span class="font14">group. </span>
   <span class="font14">Figure </span>
   <span class="font14">{border-style </span>
   <span class="font14">mice </span>
   <span class="font14">tissues </span>
   <span class="font14">colorectal </span>
   <span class="font14">expression </span>
   <span class="font14">px;} </span>
   <span class="font14">treated </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">PIK/AKT </span>
   <span class="font13">respectively </span>
   <span class="font13">targeting </span>
   <span class="font13">(Figure </span>
   <span class="font13">cellular </span>
   <span class="font13">delivery </span>
   <span class="font13">developed </span>
   <span class="font13">group </span>
   <span class="font13">CPDMAEMA-NP </span>
   <span class="font13">demonstrated </span>
   <span class="font13">growth </span>
   <span class="font12">normal </span>
   <span class="font12">progress </span>
   <span class="font12">signally </span>
   <span class="font12">various </span>
   <span class="font12">Additionally, </span>
   <span class="font12">Then, </span>
   <span class="font12">control </span>
   <span class="font12">determined </span>
   <span class="font12">inhibition </span>
   <span class="font12">pathway </span>
   <span class="font12">time </span>
   <span class="font12">uptake </span>
   <span class="font12">using </span>
   <span class="font12">*p&amp;lt;. </span>
   <span class="font12">Cancer </span>
   <span class="font12">enhanced </span>
   <span class="font12">levels </span>
   <span class="font12">obtained </span>
   <span class="font12">plus </span>
   <span class="font12">#p&amp;lt;. </span>
   <span class="font12">MEK/ERK </span>
   <span class="font12">Medical </span>
   <span class="font12">RT-qPCR </span>
   <span class="font12">apoptosis </span>
   <span class="font12">confirmed </span>
   <span class="font12">indicated </span>
   <span class="font12">revealed </span>
   <span class="font12">CPDMAEMA-NP. </span>
   <span class="font12">Cell </span>
   <span class="font12">Moreover, </span>
   <span class="font12">activity </span>
   <span class="font12">analysis </span>
   <span class="font12">cells. </span>
   <span class="font12">inhibited </span>
   <span class="font12">level </span>
   <span class="font12">miRNAs </span>
   <span class="font12">obvious </span>
   <span class="font12">pcDNA.  miR--p </span>
   <span class="font12">peptides </span>
   <span class="font12">results </span>
   <span class="font12">shown </span>
   <span class="font11">Hospital </span>
   <span class="font11">NPTX </span>
   <span class="font11">Tumor </span>
   <span class="font11">circulation </span>
   <span class="font11">decoration </span>
   <span class="font11">different </span>
   <span class="font11">dramatically </span>
   <span class="font11">efficacy </span>
   <span class="font11">exhibited </span>
   <span class="font11">experiments. </span>
   <span class="font11">peptide </span>
   <span class="font11">px; </span>
   <span class="font11">survival </span>
   <span class="font11">transfection </span>
   <span class="font11">{font-family </span>
   <span class="font11"> h. </span>
   <span class="font11">China). </span>
   <span class="font11">MCT </span>
   <span class="font11">accumulation </span>
   <span class="font11">assay </span>
   <span class="font11">cells, </span>
   <span class="font11">detected </span>
   <span class="font11">evaluation </span>
   <span class="font11">font-size </span>
   <span class="font11">invasion </span>
   <span class="font11">loaded </span>
   <span class="font11">rate </span>
   <span class="font11">regulation </span>
   <span class="font11">resulted </span>
   <span class="font11">significantly </span>
   <span class="font11">studies </span>
   <span class="font11">treatment </span>
   <span class="font11">(A) </span>
   <span class="font11">(B) </span>
   <span class="font11">China </span>
   <span class="font11">PDMAEMA </span>
   <span class="font11">PDMAEMA-NP, </span>
   <span class="font11">able </span>
   <span class="font11">activation </span>
   <span class="font11">cancer. </span>
   <span class="font11">double; </span>
   <span class="font11">down-regulated </span>
   <span class="font11">drug </span>
   <span class="font11">fluorescent </span>
   <span class="font11">followed </span>
   <span class="font11">increase </span>
   <span class="font11">injected </span>
   <span class="font11">lower </span>
   <span class="font11">mechanisms </span>
   <span class="font11">miR--p, </span>
   <span class="font11">organs </span>
   <span class="font11">patients </span>
   <span class="font11">pcDNA.  miR--p, </span>
   <span class="font11">present </span>
   <span class="font11">quantitatively </span>
   <span class="font11">samples </span>
   <span class="font11">signal </span>
   <span class="font11">signaling </span>
   <span class="font11">simultaneously </span>
   <span class="font11">study, </span>
   <span class="font11">tumor-bearing </span>
   <span class="font11">vivo </span>
   <span class="font11">(A), </span>
   <span class="font11">(E) </span>
   <span class="font11">CRC. </span>
   <span class="font11">HCT </span>
   <span class="font11">Liaoning </span>
   <span class="font11">ability </span>
   <span class="font11">anti-tumor </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">carcinoma </span>
   <span class="font11">contributed </span>
   <span class="font11">experiments </span>
   <span class="font11">expressions </span>
   <span class="font11">formulations. </span>
   <span class="font11">improved </span>
   <span class="font11">leaded </span>
   <span class="font11">mainly </span>
   <span class="font11">markedly </span>
   <span class="font11">miRNA </span>
   <span class="font11">microRNAs </span>
   <span class="font11">migration, </span>
   <span class="font11">observed </span>
   <span class="font11">p-AKT, </span>
   <span class="font11">p-ERK </span>
   <span class="font11">p-PIK, </span>
   <span class="font11">pathway. </span>
   <span class="font11">purchased </span>
   <span class="font11">role </span>
   <span class="font11">series </span>
   <span class="font11">size </span>
   <span class="font11">solid; </span>
   <span class="font11">target </span>
   <span class="font11">tumors </span>
   <span class="font11">wide </span>
   <span class="font11">work </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(C) </span>
   <span class="font10">(D) </span>
   <span class="font10">-Fu. </span>
   <span class="font10">CPDMAEMA-NP, </span>
   <span class="font10">Caco-, </span>
   <span class="font10">Department </span>
   <span class="font10">Oncol:–. </span>
   <span class="font10">PDMAEMA-NP. </span>
   <span class="font10">Qualitative </span>
   <span class="font10">Quantitative </span>
   <span class="font10">Science </span>
   <span class="font10">University, </span>
   <span class="font10">Western </span>
   <span class="font10">achieve </span>
   <span class="font10">achieved </span>
   <span class="font10">active </span>
   <span class="font10">added </span>
   <span class="font10">amplified </span>
   <span class="font10">bold </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">closely </span>
   <span class="font10">contrast, </span>
   <span class="font10">courier; </span>
   <span class="font10">decorated </span>
   <span class="font10">deliver </span>
   <span class="font10">designed </span>
   <span class="font10">distribution </span>
   <span class="font10">elevation </span>
   <span class="font10">em; </span>
   <span class="font10">evaluated </span>
   <span class="font10">investigated </span>
   <span class="font10">investigated. </span>
   <span class="font10">investigation </span>
   <span class="font10">miR--p. </span>
   <span class="font10">microRNA </span>
   <span class="font10">modification </span>
   <span class="font10">nanocomplexes. </span>
   <span class="font10">negative </span>
   <span class="font10">negatively </span>
   <span class="font10">p-MEK </span>
   <span class="font10">particle </span>
   <span class="font10">plasmid </span>
   <span class="font10">plates </span>
   <span class="font10">pt;} </span>
   <span class="font10">quantitative </span>
   <span class="font10">related </span>
   <span class="font10">reported </span>
   <span class="font10">subsequently </span>
   <span class="font10">supported </span>
   <span class="font10">therapeutic </span>
   <span class="font10">therapy. </span>
   <span class="font10">tissues. </span>
   <span class="font10">treatments. </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
